Overview
This IG will use FHIR to support electronic health data exchange of cancer pathology information between a hospital or facility-based laboratory information system (LIS) and hospital or facility-based electronic health record (EHR) system. The goal of this project is to create one FHIR implementation guide (US Realm) that will be based on NAACCR Standards for Cancer Registries Volume V, Laboratory Electronic Reporting Pathology Version 5, May 2020 (Revised 2020).
The IG will use the FHIR message bundle paradigm and profile data from NAACCR Volume 5, including MessageHeader, DiagnosticReports, and Specimen. It will be based on US Core profiles where possible, binding to terminologies such as SNOMED CT and the North American Association of Central Cancer Registries Volume II, Data Standards & Data Dictionary. It will also include CAP eCC Protocol CKey Identifier to SNOMED translation.
Timeline & Status
| PSS Consensus Review period | 2021-01-26 to 2021-03-02 |
|---|---|
| Connectathon | May 2021 |
| NIB | |
| Ballot | September 2021 |
| Recon Package Approval | |
| Connectathon | May 2021 |
| Connectathon | January 2022 |
| Connectathon | May 2022 |
| Publication | Fall 2022 |
Meeting Information
Wednesdays at 10:00 am ET
________________________________________________________________________________
Microsoft Teams meeting
Join on your computer or mobile app
Click here to join the meeting
Or call in (audio only)
+1 208-996-1659,,939072358# United States, Boise
Phone Conference ID: 939 072 358#
Find a local number | Reset PIN
________________________________________________________________________________
Project Information
| Project Insight Number | 1686 |
|---|---|
| HL7 Sponsor(s) | Orders and Observations |
| Project Proposal | Accepted 2021-01-28 |
| PSS | PSS-1688 |
| FHIR IG Proposal | |
| Github | https://github.com/HL7/cancer-reporting |
| May 2021 Connectathon | |
| January 2022 Connectathon | 2022-01 Cancer Pathology Reporting to EHRs *tested in MedMorph track |
| May 2022 Connectathon | 2022 - 05 Connectathon 30 |
| September 2022 Connectathon | 2022-09 Cancer Electronic Pathology Reporting (Cancer FHIR IG & IHE SDC on FHIR) |
| Cancer FHIR IG CI Build | |
O&O (Sponsor WG) Approval to start publication process | Ruby Nash/Riki Merrick - In favor: 12, Abstain: 4, Against: 0 |
| FMG Approval of STU Publication Request by the OO WG for HL7 FHIR® IG: Cancer Pathology Data Sharing | Sent out with 9/2 e-Vote, approved by FMG 9/7 |
Project Team:
Lantana Consulting Group (IG developers)
- Wendy Wise, Project Director (wendy.wise@lantanagroup.com)
- Ruby Nash, Project Manager (ruby.nash@lantanagroup.com)
- Dave DeRoode, CDA/FHIR Analyst (david.deroode@lantanagroup.com)
- Zabrina Gonzaga, Clinical Advisor and Terminology SME (zabrina.gonzaga@lantanagroup.com)
- Rick Geimer, FHIR SME (rick.geimer@latanagroup.com)
Centers for Disease Control and Prevention
- Sandy Jones, Public Health Advisor, (SFT1@cdc.gov)
- Caitlin Kennedy, Health Scientist, (mhy5@cdc.gov)
- Vernellia Johnson, Cancer Surveillance Branch Acting Deputy Director (hft9@cdc.gov)